BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3004519)

  • 21. Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin.
    Ware JA; Johnson PC; Smith M; Salzman EW
    J Clin Invest; 1986 Mar; 77(3):878-86. PubMed ID: 3081576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement by electrical impedance aggregometry of porcine platelets response to selected physiological agonists.
    Gewirtz H; Steiner M; Sasken H; Most AS
    Proc Soc Exp Biol Med; 1985 Jul; 179(3):324-30. PubMed ID: 3923491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine. Studies of a familial platelet alpha 2-adrenergic receptor defect.
    Rao AK; Willis J; Kowalska MA; Wachtfogel YT; Colman RW
    Blood; 1988 Feb; 71(2):494-501. PubMed ID: 2827817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism between thrombin and epinephrine in human platelets: different dose-response relationships for aggregation and dense granule secretion.
    Steen VM; Holmsen H
    Thromb Haemost; 1985 Oct; 54(3):680-3. PubMed ID: 4089798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation with epinephrine of macaque platelet aggregation by other agonists: implications for studies on human atherosclerosis.
    Beatty CH; Howard CF; Caruso V
    Thromb Res; 1986 Feb; 41(4):447-58. PubMed ID: 3083525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between ATP and catecholamines in stimulation of platelet aggregation.
    Birk AV; Leno E; Robertson HD; Bolotina VM; Szeto HH
    Am J Physiol Heart Circ Physiol; 2003 Feb; 284(2):H619-25. PubMed ID: 12388296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggregation characteristics of platelets in stored concentrates of human blood.
    Nolan ML; Harrington MG
    Biochem Soc Trans; 1995 May; 23(2):373S. PubMed ID: 7672404
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute reduction in human platelet alpha 2-adrenoreceptor affinity for agonist by endogenous and exogenous catecholamines.
    Hollister AS; FitzGerald GA; Nadeau JH; Robertson D
    J Clin Invest; 1983 Oct; 72(4):1498-505. PubMed ID: 6138365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion.
    White JG; Rao GH; Gerrard JM
    Am J Pathol; 1977 Aug; 88(2):387-402. PubMed ID: 879276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adrenergic receptors of blood platelets].
    Lanza F; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1987; 29(6):407-24. PubMed ID: 2837727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet antiaggregating activity of imolamine: in vitro studies.
    Tremoli E; Maderna P; Cocuzza E; Mantero O
    Pharmacol Res Commun; 1979 Jan; 11(1):31-8. PubMed ID: 424437
    [No Abstract]   [Full Text] [Related]  

  • 34. Arginine vasopressin release from human platelets after irreversible aggregation.
    Anfossi G; Mularoni E; Trovati M; Massucco P; Mattiello L; Emanuelli G
    Clin Sci (Lond); 1990 Jan; 78(1):113-6. PubMed ID: 2153488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine.
    Corby DG; O'Barr TP
    Dev Pharmacol Ther; 1981; 2(4):215-25. PubMed ID: 6266790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F; Cazenave JP
    Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the aggregation responses of camel platelets.
    Al Ghumlas AK; Gader AG
    Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of aspirin on plasma and platelet catecholamine levels, and platelet function in normal man.
    Smith CC; Wilson AP; Betteridge DJ
    Clin Auton Res; 1993 Feb; 3(1):49-53. PubMed ID: 8477181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function.
    Devaraja S; Girish KS; Santhosh MS; Hemshekhar M; Nayaka SC; Kemparaju K
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):419-23. PubMed ID: 23343693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.